ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0216

15 Years of Experience in Alkaline Phosphatase (ALP)-Based Calcium Replacement Protocol for Postparathyroidectomy Patients with ESKD

Session Information

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Chong, Sin Yoong, Singapore General Hospital, Singapore, Singapore
  • Chan, Choong Meng, Singapore General Hospital, Singapore, Singapore
  • Choong, Lina, Singapore General Hospital, Singapore, Singapore
  • Wong, Jiunn, Singapore General Hospital, Singapore, Singapore
Background

Despite routine calcimimetic use, parathyroidectomy (PTx) remains useful. Our prior ALP-based post-PTx calcium replacement protocol preemptively started intravenous (IV) and oral calcium (Ca) in immediate post-PTx patients based on their ALP levels. Ca infusion were run over 12 hours. This reduced incidences of hypocalcemia from hungry bone syndrome (HBS), but patients frequently experienced hypercalcemia from over replacement. Hence, the protocol was amended and audited.

Methods

After analyzing initial data from 195 patients (2008-2013), we halved the postoperative day IV Ca infusion time from 12 to 6 hours, maintaining the same Ca concentration. We then performed a clinical audit on patients who had PTx using anonymized patient data from the EMR (2020-2023).

Results

Total of 68 cases were identified. Median ALP on day of surgery was 312U/L (163-585). Mean cCa level was 2.41mmol/L±0.21 pre-op and 2.17mmol/L±0.21 post op. Mean cCA level from POD1 to POD7 were 2.29mmol/L±0.33, 2.31mmol/L±0.23, 2.44mmol/L±0.30, 2.47mmol/L±0.35, 2.51mmol/L±0.47, 2.46mmol/L±0.60 and 2.48mmol/L±0.80 respectively. Patients received a mean of 86mls±80 IV
10% Ca gluconate given immediately post surgery. Mean IV Ca given from POD1 to POD7 were 110mls±103, 103mls±82, 91mls±85, 78mls±68, 75mls±66, 75mls±59 and 75mls±57 respectively. We found that patients received 16% less IV Ca with the amended protocol. Mean oral elemental Ca post op from day of surgery to POD 7 were: 1.04g±0.26, 3.10g±0.78, 3.72g±1.2, 3.89g±1.53, 3.93g±1.67, 3.92g±1.60, 4.16g±1.64 and 3.82g±1.85 respectively. (Fig 1)

Conclusion

Post-amendment, total IV Ca received post-PTx and hypercalcemia risk were reduced, while not increasing rates of severe hypocalcemia from HBS. Regular clinical protocol audits are required to optimize patient care.

Fig 1

Digital Object Identifier (DOI)